Profil
Jeffrey H.
Lawson is the founder of InnAVasc Medical, Inc. (founded in 2013) where he holds the title of Director.
He is currently the Vice Chairman & Chief Surgical Officer at Humacyte Global, Inc. (since 2015) and also holds director positions at Vascular Access Society of The Americas, Kidney Health Initiative, and Foundation For Women & Girls With Blood Disorders.
Dr. Lawson previously served as the Chief Executive Officer at VarmX BV (2023-2024) and as the Director & Chief Surgical Officer at Humacyte, Inc. (2021).
He obtained a doctorate degree from the University of Vermont College of Medicine in 1991.
Postes actifs de Jeffrey Lawson
| Sociétés | Poste | Début |
|---|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Directeur/Membre du Conseil | 01/07/2018 |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Fondateur | 13/05/2013 |
Kidney Health Initiative | Directeur/Membre du Conseil | - |
Vascular Access Society of The Americas
Vascular Access Society of The Americas The private company is based in Lexington, KY. Its membership includes vascular surgeons, nephrologists, interventional radiologists, nurses, researchers, and industry leaders who work to advance dialysis access through education, research, advocacy, and clinical programs. VASA promotes interdisciplinary collaboration and continuous learning through annual scientific meetings, practicums, webinars, podcasts, and continuing medical education programs. The society publishes the peer-reviewed Journal of Vascular Access six times annually, featuring clinical and laboratory research, emerging technologies, and best practices in vascular access management. VASA supports research to develop new treatments and standards aimed at improving patient outcomes and reducing complications, and it advocates for professionals by engaging with healthcare institutions and policymakers to promote research funding, education, and evidence-based guidelines. The society also fosters international partnerships to accelerate innovation, standardize care, and expand access to safer vascular access solutions. The Vascular Access Society of the Americas (VASA) is a multidisciplinary professional organization founded in 2004, dedicated to improving vascular access care, particularly for patients requiring dialysis. | Directeur/Membre du Conseil | - |
Foundation For Women & Girls With Blood Disorders
Foundation For Women & Girls With Blood Disorders Miscellaneous Commercial ServicesCommercial Services Operates as a foundation that diagnoses and manages blood disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeffrey Lawson
| Sociétés | Poste | Fin |
|---|---|---|
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Directeur Général | 12/11/2024 |
| HUMACYTE, INC. | Directeur/Membre du Conseil | 31/12/2021 |
Formation de Jeffrey Lawson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
University of Vermont College of Medicine
University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vascular Access Society of The Americas
Vascular Access Society of The Americas The private company is based in Lexington, KY. Its membership includes vascular surgeons, nephrologists, interventional radiologists, nurses, researchers, and industry leaders who work to advance dialysis access through education, research, advocacy, and clinical programs. VASA promotes interdisciplinary collaboration and continuous learning through annual scientific meetings, practicums, webinars, podcasts, and continuing medical education programs. The society publishes the peer-reviewed Journal of Vascular Access six times annually, featuring clinical and laboratory research, emerging technologies, and best practices in vascular access management. VASA supports research to develop new treatments and standards aimed at improving patient outcomes and reducing complications, and it advocates for professionals by engaging with healthcare institutions and policymakers to promote research funding, education, and evidence-based guidelines. The society also fosters international partnerships to accelerate innovation, standardize care, and expand access to safer vascular access solutions. The Vascular Access Society of the Americas (VASA) is a multidisciplinary professional organization founded in 2004, dedicated to improving vascular access care, particularly for patients requiring dialysis. | |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Kidney Health Initiative | |
Humacyte, Inc.
Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Foundation For Women & Girls With Blood Disorders
Foundation For Women & Girls With Blood Disorders Miscellaneous Commercial ServicesCommercial Services Operates as a foundation that diagnoses and manages blood disorders | Commercial Services |
















